Michael J. Whalen
Yale New Haven Hospital, Mount Sinai Hospital, George Washington University
Papers
8
Total Citations
94
H-Index
6
About
Michael J. Whalen is a leading urologic oncologist whose research centers on optimizing surgical outcomes for kidney and prostate cancers, with a particular focus on robotic-assisted techniques. His most impactful work challenges established practices in partial nephrectomy, demonstrating through a 2016 propensity-score analysis (39 citations) that selective arterial clamping offers no advantage over main renal artery clamping in patients with normal renal function—a finding that has influenced intraoperative decision-making. Whalen has also made critical contributions to prostate cancer surgery, notably showing that close surgical margins after radical prostatectomy mimic the biochemical recurrence rates of positive margins (14 citations), redefining how surgeons interpret resection adequacy. His population-based studies reveal how robotic platform adoption increases partial nephrectomy utilization (11 citations), while his analysis of transperitoneal approaches for anterior versus posterior renal masses (9 citations) provides practical guidance for surgical planning. Whalen’s work on erectile dysfunction prevention after prostatectomy and oncologic outcomes for robotic cystectomy further underscores his commitment to balancing cancer control with quality of life. With over 90 total citations, his research continues to shape evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8